@article {7657,
	title = {Increased expression of cyclin-D1 on trephine bone marrow biopsies independently predicts for shorter overall survival in patients with multiple myeloma treated with novel agents},
	journal = {American Journal of Hematology},
	volume = {87},
	year = {2012},
	note = {Cited By :3Export Date: 21 February 2017},
	month = {2012},
	pages = {734 - 736},
	abstract = {Multiple myeloma (MM) comprises 1\% of all malignancies and 13\% of hematological malignancies in the Caucasian population. Yearly incidence is 4/100,000 in the US and is higher in blacks and males [1]. The pathogenesis of the disease is relatively unknown; several chromosomal abnormalities have been related to the development of the disease, but none is characteristic of MM. Cyclin-D1 is a protein encoded by the CCND1 (bcl-1) gene on chromosome 11q13, and is an important regulator of G1 to S phase progression.},
	url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-84862510109\&doi=10.1002\%2fajh.23223\&partnerID=40\&md5=812ce2bea3e294020fbb2469e3f4b357},
	author = {Tasidou, A. and Roussou, M. and Terpos, E. and Kastritis, E. and Gkotzamanidou, M. and Gavriatopoulou, M. and Migkou, M. and Eleutherakis-Papaiakovou, E. and Nikitas, N. and Anagnostou, D. and Dimopoulos, M.A.}
}
